KLK3 and prostate cancer: The higher proportions of testing in older age-groups in Stockholm rises concern, given frequent opportunistic testing may excerbate the risk of overdiagnosis and overtreatment [30] and low PSA values having lower probability of experiencing aggressive prostate cancer or death in these age-groups [31].